Articles From: UPDATE: 5 things you won't learn from reading Geithner's book to UPDATE: Bank of New York Mellon to sell NYC headquarters


2014/5/16
By Greg Robb, MarketWatch In Timothy Geithner's new book "Stress Test," he offers a defense of his actions during the crisis, first as president of the New York Federal Reserve Bank -- the eyes and ears of the government on Wall Street -- and later as President Barack Obama's Treasury Secretary.
Sign-up for UPDATE: 5 things you won't learn from reading Geithner's book investment picks
2014/5/22
By Catey Hill, MarketWatch Office Depot is recalling more than a million desk chairs because they may send workers tumbling onto the floor, making some consumers wonder: Are there other dangers lurking in my office that I may not know about?
Sign-up for UPDATE: 7 disgusting dangers lurking around your office investment picks
2014/5/16
By Jeff Reeves Amazon is one of the most prominent flame-outs of 2014.
Sign-up for UPDATE: 7 reasons Amazon's stock is going nowhere in 2014 investment picks
2014/5/19
By Jeff Reeves Amazon is one of the most prominent flame-outs of 2014.
Sign-up for UPDATE: 7 reasons Amazon's stock is going nowhere in 2014 investment picks
2014/5/13
By MarketWatch Toys that stand the test of time are those that capture a child's imagination and creativity.
Sign-up for UPDATE: 8 favorite '60s toys you can still buy for family fun investment picks
2014/5/19
By Jack Marshall Advertising holding company Publicis Groupe and social-networking service Facebook have struck a major multiyear partnership, Publicis announced Monday.
Sign-up for UPDATE: Ad giant Publicis and Facebook in a relationship investment picks
By Jon Friedman, MarketWatch The New York Times Co.
Sign-up for UPDATE: All the N.Y. Times news that's giving people fits investment picks
2014/5/13
By Julie Steinberg Anthony Noto, a top Goldman Sachs Group Inc. banker who shepherded Twitter Inc.'s initial public offering, is leaving the firm to join a hedge fund.
Sign-up for UPDATE: Anthony Noto to leave Goldman Sachs for Coatue investment picks
By Daisuke Wakabayashi and Rolfe Winkler Apple Inc. and Google Inc. agreed to dismiss all lawsuits between them, bringing to a close a patent dispute between the iPhone maker and the Web giant's Motorola unit.
Sign-up for UPDATE: Apple and Google agree to dismiss all lawsuits investment picks
By Daisuke Wakabayashi Apple Inc. (AAPL) reported its second straight quarter of double-digit percentage growth in iPhone sales as it heads into a major refresh of the company's flagship product.
Sign-up for UPDATE: Apple profit tops expectations on strong iPhone sales investment picks
By Sue Chang and Saumya Vaishampayan, MarketWatch SAN FRANCISCO (MarketWatch) -- Apple Inc. rose Monday to reclaim the $600-mark in the wake of a deal with Google Inc. to settle all lawsuits, while AT&T slid following the announcement of its multi-billion DirecTV buyout deal.
Sign-up for UPDATE: Apple reclaims $600 mark; AT&T down on DirecTV deal investment picks
By Sue Chang and Saumya Vaishampayan, MarketWatch SAN FRANCISCO (MarketWatch) -- Apple Inc. rose Monday to reclaim the $600-mark in the wake of a deal with Google Inc. to settle all lawsuits, while Campbell Soup Co.
Sign-up for UPDATE: Apple reclaims $600 mark; Campbell Soup falls investment picks
By Sue Chang and Saumya Vaishampayan, MarketWatch SAN FRANCISCO (MarketWatch) -- Apple Inc. rose Monday to reclaim the $600-mark in the wake of a deal with Google Inc. to settle all lawsuits while Campbell Soup Co.
Sign-up for UPDATE: Apple reclaims $600 mark; Campbell Soup falls investment picks
By Daisuke Wakabayashi Enemies of the early personal-computer wars, Apple Inc. (AAPL) and International Business Machines Corp.
Sign-up for UPDATE: Apple, IBM team up to create apps, sell phones investment picks
By Rex Crum, MarketWatch SAN FRANCISCO (MarketWatch)--Gains from Applied Materials Inc., Rackspace Hosting Inc. and Autodesk Inc.stood out among tech stocks Friday and helped the sector shake off early losses and close the week out on an upbeat note.
Sign-up for UPDATE: Applied Materials, Rackspace lead tech gains investment picks
2014/5/13
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asia stocks were mostly higher on Tuesday, tracking overnight gains in the U.S., while Shanghai markets slipped as China's April economic data slightly missed expectations.
Sign-up for UPDATE: Asia stocks mostly higher after China data investment picks
2014/5/16
By Daniel Inman Indian stocks closed at a record high Friday, as the anticipation over the next government propelled the Sensex higher, while Japanese stocks were weighed by a stronger yen and more poor corporate earnings.
Sign-up for UPDATE: Asia stocks: Indian shares surge on poll results investment picks
2014/5/23
By Laura He, MarketWatch HONG KONG (MarketWatch) -- Asian stocks were mostly higher on Friday, following a positive U.S. lead, while Thai markets fell after the country's military took control in a coup.
Sign-up for UPDATE: Asian stocks mostly up; Thai markets fall after coup investment picks
2014/5/21
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 index broke a two-day losing streak on Wednesday, with AstraZeneca lifting the benchmark after a group of shareholders tried to revive the Pfizer bid.
Sign-up for UPDATE: AstraZeneca boosts FTSE 100 after two days in red investment picks
2014/5/19
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets moved lower on Monday, with AstraZeneca PLC leading the charge south after rejecting a sweetened Pfizer offer, while mining firms declined on added signs of a slowdown in the Chinese housing market.
Sign-up for UPDATE: AstraZeneca bruises Stoxx 600 after rejecting Pfizer investment picks
2014/5/19
By Ian Walker LONDON --
Sign-up for UPDATE: AstraZeneca rejects higher 'final' offer from Pfizer investment picks
MADRID (MarketWatch) -- AstraZeneca PLC (AZN)(uk:azn) on Monday rejected a final offer made by Pfizer Inc. (PFE) for its rival.
Sign-up for UPDATE: AstraZeneca rejects Pfizer's final proposal, says undervalues company investment picks
2014/5/19
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Europe's benchmark stock index moved lower on Monday, with AstraZeneca PLC leading the charge south after rejecting a sweetened Pfizer Inc. offer, while mining firms declined on added signs of a slowdown in the Chinese housing market.
Sign-up for UPDATE: AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer investment picks
2014/5/19
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets moved lower on Monday, with AstraZeneca PLC leading the charge south after rejecting a sweetened Pfizer Inc. offer, while mining firms declined on added signs of a slowdown in the Chinese housing market.
Sign-up for UPDATE: AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer investment picks
By Thomas Gryta and Shalini Ramachandran The boards of AT&T Inc. and DirecTV plan to meet on Sunday to approve a combination of the two companies, people familiar with the matter said, in a deal that will create a new pay-television giant as its rivals in the cable industry bulk up.
Sign-up for UPDATE: AT&T set to pay mid-$90s per share for DirecTV investment picks
By Michael Kitchen, MarketWatch LOS ANGELES (MarketWatch) -- AT&T Inc. said Sunday it will buy satellite-television provider DirecTV in a stock-and-cash deal worth $67.1 billion when including the latter's current debt.
Sign-up for UPDATE: AT&T strikes deal for DirecTV worth $67.1 billion investment picks
2014/5/20
By Jon Friedman, MarketWatch The media and telecommunications industries, while growing on a massive scale, are actually getting smaller.
Sign-up for UPDATE: AT&T ups the ante as pay-TV monopoly nears investment picks
2014/5/19
By Jon Friedman, MarketWatch The media and telecommunications industries, while growing on a massive scale, are actually getting smaller.
Sign-up for UPDATE: AT&T ups the ante as pay-TV monopoly nears investment picks
2014/5/21
By Eliot Brown and Keiko Morris Bank of New York Mellon Corp.
Sign-up for UPDATE: Bank of New York Mellon to sell NYC headquarters investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: UPDATE: 5 things you won't learn from reading Geithner's book to UPDATE: Bank of New York Mellon to sell NYC headquarters
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry